Notably, blocking CXCL12–CXCR4 interaction with the CXCR4 inhibitor plerixafor (AMD3100) disrupts MM cell contacts with the BM microenvironment [13], leading to MM cell mobilization into the circulation [14]. This evidence concerns the gene CXCL12 and Miyoshi myopathy.